BRCA2 and ovarian carcinoma: These DSBs can be repaired in normal cells with proficient HRR; however, DSBs cannot be efficiently repaired in BRCA1- or BRCA2-mutated breast and ovarian cancer cells due to HRR deficiency (HRD).